Esra Çakmak Taşkın

Esra Çakmak Taşkın

Auto-generated profile, based on publicly available information

Esra Çakmak Taşkın

Ankara University Faculty of Medicine, Department of Pediatric Infectious Diseases, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
HOHalil Ozdemir
Halil Ozdemir
NDNihal Ekin Dağ
Nihal Ekin Dağ
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
HKHatice Kübra Konca
Hatice Kübra Konca
GAGul Arga
Gul Arga
EIErdal İnce
Erdal İnce
In Turkey, the seven-valent pneumococcal conjugated vaccine (PCV7) was included in the childhood national immunization programme in April 2008 and was replaced by the 13-valent pneumococcal conjugated vaccine (PCV13) in April 2011. In this retrospective, single-center study, it was aimed to determine the serotype distribution and antimicrobial resistance in Streptococcus pneumoniae isolates of pediatric patients with invasive pneumococcal disease (IPD) after the introduction of PVC7 and PVC13. Fifty pediatric patients diagnosed with meningitis and sepsis/bacteremia between October 2009 and October 2019 were included in the study. The pediatric patient group consisted of previously healthy patients diagnosed with meningitis and sepsis/bacteremia with S.pneumoniae isolated in their blood or cerebrospinal fluids. Patients with pneumonia-associated bacteremia and empyema were not included in the study. Serotyping of the isolates was performed by Quellung reaction using specific antisera (Statens Serum Institute, Denmark) and antibiotic (penicillin and ceftriaxone) susceptibility was determined by antibiotic gradient method based on Clinical Laboratory Standards Institute (CLSI) criteria. Of the children, 29 (58%) were boys and 21 (42%) were girls. The median age of the patients was 19 months (1 month-18 year). When the children under the age of five were evaluated, it was found that 30 (79%) patients were diagnosed with occult bacteremia/sepsis and 8 (21%) with meningitis. The overall annual incidence rate of IPD among the healthy children aged <5 years decreased significantly from 9.35/100000 to 0.83/100000 (p0.05). The most common serotypes detected in isolates were 19F, 23F, 7F, 31 and 24B. According to the minimum inhibitory concentration values of the isolates recovered from patients with meningitis, penicillin and ceftriaxone resistance rates were found as 43.9% and 9.8%, respectively. In conclusion, our study showed that there was a 91.1% decrease in the incidence of IPD in healthy children aged under five years after the implementation of PCV7 and PCV13. It was determined that while the rate of serotypes in vaccine content decreased, there was an increase in non-vaccine serotypes. In addition no significant change was observed in antibiotic resistance rates over the years.

15 September 2020 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
DÇDilara Beşli Çelik
Dilara Beşli Çelik
AGAytaç Göktuğ
Aytaç Göktuğ
DKDeniz Karakaya
Deniz Karakaya
DTDeniz Tekin
Deniz Tekin
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
EÇErgin Çiftçi
Ergin Çiftçi

1 December 2020 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
EÇErgin Çiftçi
Ergin Çiftçi
GAGul Arga
Gul Arga
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
HKHatice Kübra Konca
Hatice Kübra Konca
HOHalil Ozdemir
Halil Ozdemir

1 June 2020 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
EÇErgin Çiftçi
Ergin Çiftçi
HKHatice Kübra Konca
Hatice Kübra Konca
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
GAGul Arga
Gul Arga
SÖSeval Özen
Seval Özen
EIErdal Ince
Erdal Ince

15 December 2020 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
EÇErgin Çiftçi
Ergin Çiftçi
GAGul Arga
Gul Arga
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
HKHatice Kübra Konca
Hatice Kübra Konca
HOHalil Ozdemir
Halil Ozdemir

15 December 2020 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
HGHatice Büşra Kütükçü Gül
Hatice Büşra Kütükçü Gül
HKHatice Kübra Konca
Hatice Kübra Konca
GAGul Arga
Gul Arga
HOHalil Ozdemir
Halil Ozdemir
EIErdal İnCe
Erdal İnCe
Leishmania is a vector-induced endemic tropical disease caused by protozoans. The most common cutaneous, mucosal and visceral forms are the cutaneous form. The main drugs in treatment are pentavalent antimony compounds, but their side effects create limitation of use. Local antimony compounds are used primarily in the treatment of cutaneous leishmaniasis. In some cases, alternative treatment modalities are required due to insufficient response to local treatment. Systemic amphotericin B treatment is one of the alternative treatments. In a patient who developed cutaneous leishmania at 21 months and who did not respond with local meglumine antimoniate therapy, a total of 21 mg / kg dose of systemic amphotericin B was given intermittently and successful results were obtained.